AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
AGE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -1.49%176.120.7%$1154.91m
LLYEli Lilly & Co. -0.17%368.681.1%$1075.50m
MRKMerck & Co., Inc. -0.98%108.930.7%$992.38m
PFEPfizer Inc. -2.01%49.710.9%$934.38m
ABBVAbbVie, Inc. -0.11%163.761.9%$884.04m
BMYBristol-Myers Squibb Co. -0.98%79.911.1%$741.36m
AZNAstraZeneca Plc 0.21%68.561.0%$355.43m
HZNPHorizon Therapeutics Plc -1.66%96.855.4%$295.13m
GSKGSK Plc 7.85%37.920.3%$247.06m
IDXXIDEXX Laboratories, Inc. -1.64%415.393.9%$191.92m
NVSNovartis AG -0.25%90.730.2%$185.59m
CTLTCatalent, Inc. -5.00%48.231.9%$175.42m
ALNYAlnylam Pharmaceuticals, Inc. -2.90%219.648.0%$156.22m
NVONovo Nordisk A/S -1.03%125.770.1%$154.68m
SNYSanofi 8.06%48.550.2%$133.18m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.